What does DR. RIVERO do?

DR. RIVERO is a specialist medical practice in Genk. Private Limited, started on 24 September 2007.

What is the address of DR. RIVERO?

The registered office of DR. RIVERO is located at Oostlaan 43, 3600 Genk.

Is DR. RIVERO still active?

Yes. According to the CBE (17 September 2026) DR. RIVERO is active, legal situation “Normale toestand”, started on 24 September 2007.

Is DR. RIVERO registered on Peppol?

Yes, DR. RIVERO is registered on the Peppol network with ID 0208:0892572125.

What is the enterprise number of DR. RIVERO?

The enterprise number of DR. RIVERO is BE0892572125.

When was DR. RIVERO founded?

DR. RIVERO was founded on 24 September 2007.

Who are the directors of DR. RIVERO?

According to the 2025 annual accounts, the directors of DR. RIVERO are: Ayerza Maximo Jose Rivero.

Is DR. RIVERO a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 24 September 2007; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did DR. RIVERO make in 2025?

DR. RIVERO posted a profit after taxes of € 391,138 in financial year 2025.

What is the revenue of DR. RIVERO?

As a small company, DR. RIVERO is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 627,550.

DR. RIVERO (Private Limited) - Genk - BE0892572125

Dossier DR. RIVERO, printed on 17 September 2026 from databakkes.be/en/0892572125/dr-rivero. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

DR. RIVERO from Genk, company number BE0892572125, closed financial year 2025 with a result of € 391,138 after tax. For that financial year DR. RIVERO recorded a gross margin of € 627,550 and equity of € 1.8 million. Compared with financial year 2024, the result moved from € 334,634 to € 391,138. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 24, 2026.

What it is worth Growing

€ 1.8 million

▲ 2% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 391,138

▲ 17% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 84,569

▼ 16% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 361,593 paid out

92 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Vehicles and equipment

€ 12,873

▲ 19% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 8 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 938,212

▼ 10% vs 2024

€ 115,019 is repaid this year. At this pace the long-term loan is gone in ≈ 8 years.

Owed to suppliers

€ 6,745

▲ 12% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 82,698

▲ 40% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 500,851 Gross margin 2022: € 500,851 First fiscal year in the series	€ 559,009 Gross margin 2023: € 559,009 ▲ 12% vs 2022 (€ 500,851) Favourable step	€ 624,634 Gross margin 2024: € 624,634 ▲ 12% vs 2023 (€ 559,009) Favourable step	€ 627,550 Gross margin 2025: € 627,550 Unchanged (€ 624,634) Favourable step
Profit after taxes	€ 177,505 Profit after taxes 2022: € 177,505 First fiscal year in the series	€ 251,026 Profit after taxes 2023: € 251,026 ▲ 41% vs 2022 (€ 177,505) Favourable step	€ 334,634 Profit after taxes 2024: € 334,634 ▲ 33% vs 2023 (€ 251,026) Favourable step	€ 391,138 Profit after taxes 2025: € 391,138 ▲ 17% vs 2024 (€ 334,634) Favourable step	▲ 17%
Equity	€ 1,755,043 Equity 2022: € 1,755,043 First fiscal year in the series	€ 1,438,753 Equity 2023: € 1,438,753 ▼ 18% vs 2022 (€ 1,755,043) Unfavourable step	€ 1,773,387 Equity 2024: € 1,773,387 ▲ 23% vs 2023 (€ 1,438,753) Favourable step	€ 1,802,933 Equity 2025: € 1,802,933 ▲ 2% vs 2024 (€ 1,773,387) Favourable step	▲ 2%
Total debts	€ 1,248,974 Total debts 2022: € 1,248,974 First fiscal year in the series	€ 1,575,961 Total debts 2023: € 1,575,961 ▲ 26% vs 2022 (€ 1,248,974) Unfavourable step	€ 1,103,688 Total debts 2024: € 1,103,688 ▼ 30% vs 2023 (€ 1,575,961) Favourable step	€ 1,389,249 Total debts 2025: € 1,389,249 ▲ 26% vs 2024 (€ 1,103,688) Unfavourable step	▲ 26%
Cash	€ 52,872 Cash 2022: € 52,872 First fiscal year in the series	€ 34,273 Cash 2023: € 34,273 ▼ 35% vs 2022 (€ 52,872) Unfavourable step	€ 100,308 Cash 2024: € 100,308 ▲ 193% vs 2023 (€ 34,273) Favourable step	€ 84,569 Cash 2025: € 84,569 ▼ 16% vs 2024 (€ 100,308) Unfavourable step	▼ 16%
Land & buildings	€ 1,423,452 Land & buildings 2022: € 1,423,452 First fiscal year in the series	€ 1,317,825 Land & buildings 2023: € 1,317,825 ▼ 7% vs 2022 (€ 1,423,452) Unchanged	€ 1,231,462 Land & buildings 2024: € 1,231,462 ▼ 7% vs 2023 (€ 1,317,825) Unchanged	€ 1,183,444 Land & buildings 2025: € 1,183,444 ▼ 4% vs 2024 (€ 1,231,462) Unchanged	▼ 4%
Retained profit	€ 1,736,443 Retained profit 2022: € 1,736,443 First fiscal year in the series	€ 1,420,153 Retained profit 2023: € 1,420,153 ▼ 18% vs 2022 (€ 1,736,443) Unfavourable step	€ 1,754,787 Retained profit 2024: € 1,754,787 ▲ 24% vs 2023 (€ 1,420,153) Favourable step	€ 1,784,333 Retained profit 2025: € 1,784,333 ▲ 2% vs 2024 (€ 1,754,787) Favourable step	▲ 2%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 567,316 Dividend 2023: € 567,316 Unchanged (€ 0) Unchanged	€ 0 Dividend 2024: € 0 ▼ 100% vs 2023 (€ 567,316) Unchanged	€ 361,593 Dividend 2025: € 361,593 Unchanged (€ 0) Unchanged
Bank debt	€ 1,100,829 Bank debt 2022: € 1,100,829 First fiscal year in the series	€ 978,100 Bank debt 2023: € 978,100 ▼ 11% vs 2022 (€ 1,100,829) Favourable step	€ 1,038,626 Bank debt 2024: € 1,038,626 ▲ 6% vs 2023 (€ 978,100) Unfavourable step	€ 938,212 Bank debt 2025: € 938,212 ▼ 10% vs 2024 (€ 1,038,626) Favourable step	▼ 10%
Balance sheet total	€ 3,004,016 Balance sheet total 2022: € 3,004,016 First fiscal year in the series	€ 3,014,714 Balance sheet total 2023: € 3,014,714 Unchanged (€ 3,004,016) Unchanged	€ 2,877,075 Balance sheet total 2024: € 2,877,075 ▼ 5% vs 2023 (€ 3,014,714) Unchanged	€ 3,192,182 Balance sheet total 2025: € 3,192,182 ▲ 11% vs 2024 (€ 2,877,075) Unchanged	▲ 11%

Key figures of DR. RIVERO, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to DR. RIVERO?

What happened at DR. RIVERO in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 24, 2026 New annual accounts for financial year 2025: profit of € 391,138 (▲ 17% vs 2024). Source: NBB ↗
2007 Ayerza Maximo Jose Rivero became a director. NBB
Sep 24, 2007 Start of the company according to the CBE. KBO

In short

From € 177,505 profit in 2022 to € 391,138 profit in 2025.

Paid € 620,896 in corporate taxes since 2022.

Best year ever: 2025, with € 391,138 profit.

Paid out € 928,909 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at DR. RIVERO? We notify you, reason included.

Follow DR. RIVERO

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Ayerza Maximo Jose Rivero

DR. RIVERO

HLG 8%

Behind DR. RIVERO is Ayerza Maximo Jose Rivero. It owns 8% of HLG itself.

See the full network in the app

Directors

According to the 2025 annual accounts

Ayerza Maximo Jose Rivero

Director

since 2007

Establishments

Establishment units

Physical locations of this company

Registered office

Oostlaan 43

3600 Genk

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0892.572.125

VAT number

BE 0892.572.125

Registered office

Oostlaan 43, 3600 Genk

Names & denominations

DR. RIVERO

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

24 September 2007

Peppol

Active · Active since 4 Nov 2024

Activities · NACE

Activiteiten van medisch specialisten

Activiteiten van huisartspraktijken

View on CBE Public ↗ Annual accounts (NBB) ↗

DR. RIVERO

Financials

What happened to DR. RIVERO?

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Management

Directors

Establishments

Establishment units

Details

Frequently asked questions